Clinical Studies Needed For Nonthermal Shortwave Diathermy Devices, FDA Panel Says
This article was originally published in The Gray Sheet
Executive Summary
The Orthopaedic and Rehabilitation Advisory Panel recommended FDA require a randomized, sham-control study design with a well-defined patient population to prove safety and effectiveness for the devices. The agency is currently considering whether to retain the preamendments device category in class III or downclassify to class II.
You may also be interested in...
Regulatory Briefs: FDA Device Reclassifications, Meetings Announcements
FDA proposes class II for nonthermal shortwave therapy devices and updates regulations to reflect class II designation for neuropsychiatric assessment device. Meetings on manufacturing quality, clinical trials and medical countermeasures announced. More regulatory news.
Class Act: Status Of CDRH’s 515 Initiative
Chart updating FDA’s progress and decisions in classifying the final set of preamendment devices.
Orthopaedic Devices Panel Recommends Reclassification Of Pedicle Screw Spinal Systems
FDA’s Orthopaedic and Rehabilitation Devices Panel recommended the downclassification of pedicle screw spinal systems from class III to class II at a May 22 meeting.